Development and evaluation of the MiCheck test for aggressive prostate cancer

• Published in: Urologic oncology Vol. 38; no. 8; pp. 683.e11 - 683.e18
• Main Authors: Shore, Neal D., Pieczonka, Christopher M., Henderson, R. Jonathan, Bailen, James L., Saltzstein, Daniel R., Concepcion, Raoul S., Beebe-Dimmer, Jennifer L., Ruterbusch, Julie J., Levin, Rachel A., Wissmueller, Sandra, Le, Thao Ho, Gillatt, David, Chan, Daniel W., Campbell, Douglas H., Walsh, Bradley J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2020
• Subjects: Aged; Aged, 80 and over; Aggressive; Biomarker; Clinical study; Hematologic Tests - statistics & numerical data; Humans; Male; Middle Aged; Monte Carlo Method; Neoplasm Grading; Prostate; Prostate-Specific Antigen - blood; Prostatic Neoplasms - blood; Prostatic Neoplasms - diagnosis; Biomarker; Aggressive; Prostate; Clinical study

•MiCheck test is a blood test developed to detect aggressive prostate cancer.•Uses an algorithm containing clinical factors and soluble analytes to give a risk score.•Outperforms existing tests in differentiating aggressive from nonaggressive prostate cancer.•Has potential to significantly reduce bi...